Atlas Trials

A Study to Assess Pharmacokinetic Profiles of LY03003 and Neupro

Clinical trial NCT03733561 · COMPLETED

Trial details

NCT number
NCT03733561
Sponsor
Luye Pharma Group Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Parkinson Disease
Start date
2018-11-09
Primary completion
2018-12-23
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.